[Establishment of a predictive model of septic myocardiopathy based on left ventricular global longitudinal strain]

P L Yang1, J Yuan2, Y Chen2

  • 1Department of Critical Care Medicine, Northern Jiangsu People's Hospital, Yangzhou 225001, China.

Zhonghua Yi Xue Za Zhi
|April 18, 2022
PubMed

Insights

This study identifies key risk factors for septic cardiomyopathy, developing a predictive model using biomarkers like Hs-TnI and NT-proBNP to aid early diagnosis in sepsis patients.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Biomarker Research

Background:

  • Sepsis can lead to septic cardiomyopathy, a serious complication.
  • Early identification of risk factors and predictive markers is crucial for patient outcomes.

Purpose of the Study:

  • To identify risk factors for septic cardiomyopathy.
  • To develop a predictive model for septic cardiomyopathy using left ventricular global longitudinal strain (LV GLS) and clinical data.

Main Methods:

  • Echocardiography was used to measure LV GLS in sepsis patients.
  • Patients were categorized into septic cardiomyopathy (LV GLS > -17%) and normal cardiac function (LV GLS ≤ -17%) groups.
  • Multivariate logistic regression and ROC curve analysis were employed to identify risk factors and validate the predictive model.

Main Results:

  • Elevated levels of high sensitive troponin I (Hs-TnI), procalcitonin (PCT), lactate (Lac), and N-terminal pro-brain atriuretic peptide (NT-proBNP) were significantly higher in the septic cardiomyopathy group.
  • Hs-TnI (≥0.131 μg/L), PCT (≥40 μg/L), Lac (≥4.2 mmol/L), and NT-proBNP (≥3270 ng/L) were identified as independent risk factors.
  • The predictive model demonstrated good diagnostic performance with an AUC of 0.838.

Conclusions:

  • Hs-TnI, PCT, Lac, and NT-proBNP are independent risk factors for septic cardiomyopathy.
  • A predictive model incorporating these biomarkers shows strong diagnostic utility for septic cardiomyopathy.

Related Concept Videos